Hypotensive and sympathoinhibitory responses to selective central AT2 receptor stimulation in spontaneously hypertensive rats

Clinical Science

Volumn 129, Issue 1, 2015, Pages 81-92

  Brouwers, Sofie ^a,b,c   Smolders, Ilse ^b   Wainford, Richard D ^c   Dupont, Alain G ^b  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II type 1 receptor; Angiotensin II type 2 receptor; Blood pressure; Central nervous system; Compound 21; Hypertension

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN DERIVATIVE; COMPOUND 21; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NORADRENALIN; UNCLASSIFIED DRUG; ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; N-BUTYLOXYCARBONYL-3-(4-IMIDAZOL-1-YLMETHYLPHENYL)-5-ISOBUTYLTHIOPHENE-2-SULFONAMIDE; NITRIC OXIDE SYNTHASE; PYRIDINE DERIVATIVE; SULFONAMIDE; THIOPHENE DERIVATIVE;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG EFFECT; HYPOTENSION; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC TONE; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CONSCIOUSNESS; DRUG EFFECTS; HYPERTENSION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPECIES DIFFERENCE; WISTAR KYOTO RAT;

ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BAROREFLEX; BLOOD PRESSURE; CONSCIOUSNESS; ENZYME INHIBITORS; HYPERTENSION; IMIDAZOLES; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NOREPINEPHRINE; PYRIDINES; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 2; SPECIES SPECIFICITY; SULFONAMIDES; SYMPATHETIC NERVOUS SYSTEM; SYMPATHOLYTICS; THIOPHENES;

EID: 84940689333     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20140776     Document Type: Article

References (48)

1. de Gasparo, M., Catt, K. J., Inagami, T., Wright, J. W. and Unger, T. (2000) International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev. 52, 415-472.
2. Padia, S. H. and Carey, R. M. (2013) AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function. Pflügers Arch. 465, 99-110.
3. Namsolleck, P., Recarti, C., Foulquier, S., Steckelings, U. M. and Unger, T. (2014) AT(2) receptor and tissue injury: therapeutic implications. Curr. Hypertens. Rep. 16, 416.
4. Steckelings, U. M., Paulis, L., Namsolleck, P. and Unger, T. (2012) AT2 receptor agonists: hypertension and beyond. Curr. Opin. Nephrol. Hypertens. 21, 142-146.
5. Guyenet, P. G. (2006) The sympathetic control of blood pressure. Nat. Rev. Neurosci. 7, 335-346.
6. Dupont, A. G. and Brouwers, S. (2010) Brain angiotensin peptides regulate sympathetic tone and blood pressure. J. Hypertens. 28, 1599-1610.
7. Li, Y., Li, X. H. and Yuan, H. (2012) Angiotensin II type-2 receptor-specific effects on the cardiovascular system. Cardiovasc. Diagn. Ther. 2, 56-62.
8. Gao, L. and Zucker, I. H. (2011) AT2 receptor signaling and sympathetic regulation. Curr. Opin. Pharmacol. 11, 124-130.
9. Siragy, H. M., Inagami, T., Ichiki, T. and Carey, R. M. (1999) Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc. Natl. Acad. Sci. U.S.A. 96, 6506-6510.
10. Li, Z., Iwai, M., Wu, L., Shiuchi, T., Jinno, T., Cui, T. X. and Horiuchi, M. (2003) Role of AT2 receptor in the brain in regulation of blood pressure and water intake. Am. J. Physiol. Heart Circ. Physiol. 284, H116-H121.
11. Gao, L., Wang, W., Wang, W., Li, H., Sumners, C. and Zucker, I. H. (2008) Effects of angiotensin type 2 receptor overexpression in the rostral ventrolateral medulla on blood pressure and urine excretion in normal rats. Hypertension 51, 521-527.
12. Wan, Y., Wallinder, C., Plouffe, B., Beaudry, H., Mahalingam, A. K., Wu, X., Johansson, B., Holm, M., Botoros, M., Karlen, A. et al. (2004) Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J. Med. Chem. 47, 5995-6008.
13. Steckelings, U. M., Larhed, M., Hallberg, A., Widdop, R. E., Jones, E. S., Wallinder, C., Namsolleck, P., Dahlöf, B. and Unger, T. (2011) Non-peptide AT2-receptor agonists. Curr. Opin. Pharmacol. 11, 187-192.
14. Gao, J., Zhang, H., Le, K. D., Chao, J. and Gao, L. (2011) Activation of central angiotensin type 2 receptors suppresses norepinephrine excretion and blood pressure in conscious rats. Am. J. Hypertens. 24, 724-730.
15. Brouwers, S., Smolders, I., Massie, A. and Dupont, A. G. (2013) Angiotensin II type 2 receptor-mediated and oxide-dependent renal vasodilator response to compound 21 unmasked by angiotensin-converting enzyme inhibition in spontaneously hypertensive rats in vivo. Hypertension 62, 920-926.
16. Abdulla, M. H. and Johns, E. J. (2014) Nitric oxide impacts on angiotensin AT2 receptor modulation of high-pressure baroreflex control of renal sympathetic nerve activity in anaesthetized rats. Acta Physiol. 210, 832-844.
17. Schelman, W. R., Kurth, J. L., Berdeaux, R. L., Norby, S. W. and Weyhenmeyer, J. A. (1997) Angiotensin II type-2(AT2) receptor-mediated inhibition of NMDA receptor signalling in neuronal cells. Brain Res. Mol. Brain Res. 48, 197-205.
18. Sosa-Canache, B., Cierco, M., Gutierrez, C. I. and Israel, A. (2000) Role of bradykinins and nitric oxide in the AT2 receptor-mediated hypotension. J. Hum. Hypertens. 14, S40-S46.
19. Qadri, F., Carretero, O. A. and Scicli, A. G. (1999) Centrally produced neuronal nitric oxide in the control of baroreceptor reflex sensitivity and blood pressure in normotensive and spontaneously hypertensive rats. Jpn. J. Pharmacol. 81, 279-285.
20. Patel, K. P., Li, Y. F. and Hirooka, Y. (2001) Role of nitric oxide in central sympathetic outflow. Exp. Biol. Med. 226, 814-824.
21. Kapusta, D. R., Pascale, C. L., Kuwabara, J. T. and Wainford, R. D. (2013) Central nervous system Gai2-subunit proteins maintain salt resistance via a renal nerve-dependent sympathoinhibitory pathway. Hypertension 61, 368-375.
22. Xia, H., Feng, Y., Obr, T. D., Hickman, P. J. and Lazartigues, E. (2009) Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice. Hypertension 53, 210-216.
23. Vento, P. J. and Daniels, D. (2010) Repeated administration of angiotensin II reduces its dipsogenic effect without affecting saline intake. Exp. Physiol. 95, 736-745.
24. Wei, S. G., Yu, Y., Zhang, Z. H. and Felder, R. B. (2009) Angiotensin II upregulates hypothalamic AT1 receptor expression in rats via the mitogen-activated protein kinase pathway. Am. J. Physiol. Heart Circ. Physiol. 296, H1425-H1433.
25. Wainford, R. D. and Kapusta, D. R. (2010) Hypothalamic paraventricular nucleus G alpha q subunit protein pathways mediate vasopressin dysregulation and fluid retention in salt-sensitive rats. Endocrinology 151, 5403-5414.
26. Toney, G. M. and Porter, J. P. (1993) Effects of blockade of AT1 and AT2 receptors in brain on the central angiotensin II pressor response in conscious spontaneously hypertensive rats. Neuropharmacology 32, 581-589.
27. Verdonk, K., Durik, M., Abd-Alla, N., Batenburg, W. W., van den Bogaerdt, A. J., van Veghel, R., Roks, A. J., Danser, A. H. and van Esch, J. H. (2012) Compound 21 induces vasorelaxation via an endothelium-and angiotensin II type 2 receptor-independent mechanism. Hypertension 60, 722-729.
28. Bosnyak, S., Jones, E. S., Christopoulos, A., Aguilar, M. I., Thomas, W. G. and Widdop, R. E. (2011) Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors. Clin. Sci. 121, 297-303.
29. Yamori, Y. (1984) The development of Spontaneously Hypertensive Rat (SHR) and of various spontaneous rat models, and their implications. In Handbook of Hypertension, Vol. 4, Experimental and Genetic Models of Hypertension (de Jong, W, ed.), pp. 224-239, Elsevier, Amsterdam.
30. Li, X. C. and Widdop, R. E. (2004) AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR. Br. J. Pharmacol. 142, 821-30.
31. Bosnyak, S., Welungoda, I. K., Hallberg, A., Alterman, M., Widdop, R. E. and Jones, E. S. (2010) Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats. Br. J. Pharmacol. 159, 709-716.
32. Blanch, G. T., Freiria-Oliveira, A. H., Speretta, G. F., Carrera, E. J., Li, H., Speth, R. C., Colombari, E., Sumners, C. and Colombari, D. S. (2014) Increased expression of angiotensin II type 2 receptors in the solitary-vagal complex blunts renovascular hypertension. Hypertension 64, 777-783.
33. Folkow, B. (1982) Physiological aspects of primary hypertension. Physiol. Rev. 62, 347-504.
34. Bristow, J. D., Honour, A. J., Pickering, G. W., Sleight, P. and Smyth, H. S. (1969) Diminished baroreflex sensitivity in high blood pressure. Circulation 39, 48-54.
35. Veerasingham, S. J. and Raizada, M. K. (2003) Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br. J. Pharmacol. 139, 191-202.
36. Ormezzano, O., Cracowski, J. L., Quesada, J. L., Pierre, H., Mallion, J. M. and Baguet, J. P. (2008) EVAluation of the prognostic value of BARoreflex sensitivity in hypertensive patients: the EVABAR study. J. Hypertens. 26, 1373-1378.
37. Ceroni, A., Chaar, L. J., Bombein, R. L. and Michelini, L. C. (2009) Chronic absence of baroreceptor inputs prevents training-induced cardiovascular adjustments in normotensive and spontaneously hypertensive rats. Exp. Physiol. 94, 630-640.
38. Danyel, L. A., Schmerler, P., Paulis, L., Unger, T. and Steckelings, U. M. (2013) Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure. Integr. Blood Press. Control 6, 153-161.
39. Kemp, B. A., Howell, N. L., Gildea, J. J., Keller, S. R., Padia, S. H. and Carey, R. M. (2014) AT2 receptor activation induces natriuresis and lowers blood pressure. Circ. Res. 115, 388-399.
40. Hilliard, L. M., Chow, C. L., Mirabito, K. M., Steckelings, U. M., Unger, T., Widdop, R. E. and Denton, K. M. (2014) Angiotensin type 2 receptor stimulation increases renal function in female, but not male, spontaneously hypertensive rats. Hypertension 64, 378-83.
41. Fernandez-Alfonso, M. S. and Gonzalez, C. (1999) Nitric oxide and the renin-angiotensin system. Is there a physiological interplay between the systems? J. Hypertens. 17, 1355-1361.
42. Toda, N., Ayajiki, K. and Okamura, T. (2009) Control of systemic and pulmonary blood pressure by nitric oxide formed through neuronal nitric oxide synthase. J. Hypertens. 27, 1929-1940.
43. Yang, J., Chen, C., Ren, H., Han, Y., He, D., Zhou, L., Hopfer, U., Jose, P. A. and Zeng, C. (2012) Angiotensin II AT(2) receptor decreases AT(1) receptor expression and function via nitric oxide/cGMP/Sp1 in renal proximal tubule cells from Wistar-Kyoto rats. J. Hypertens. 30, 1176-1184.
44. Widdop, R. E., Matrougui, K., Levy, B. I. and Henrion, D. (2002) AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade. Hypertension 40, 516-520.
45. Savoia, C., Touyz, R. M., Volpe, M. and Schiffrin, E. L. (2007) Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients. Hypertension 49, 341-346.
46. Villela, D., Leonhardt, J., Patel, N., Joseph, J., Kirsch, S., Hallberg, A., Unger, T., Bader, M., Santos, R. A., Sumners, C. et al. (2015) Angiotensin type 2 receptor (AT2R) and receptor Mas: a complex liaison. Clin. Sci. 128, 227-234.
47. Kawano, Y., Yoshida, K., Matsuoka, H. and Omae, T. (1994) Chronic effects of central and systemic administration of losartan on blood pressure and baroreceptor reflex in spontaneously hypertensive rats. Am. J. Hypertens. 7, 536-542.
48. Sevápessôa, B., van der Lubbe, N., Verdonk, K., Roks, A. J., Hoorn, E. J. and Danser, A. H. (2013) Key developments in renin-angiotensin-aldosterone system inhibition. Nat. Rev. Nephrol. 9, 26-36.